In conclusion, this study provides robust quantitative evidence that weight regain is not a treatment failure but a predictable biological response and must be anticipated and addressed in clinical practice
While these findings are encouraging, real-world use in dialysis must be cautious, individualized, and always done with nephrology input
Current evidence suggests GLP-1 receptor activation in the brain contributes to reduced food intake, altered food preferences, improved glycemic control, and potentially neuroprotective effects
If you're flying from a UK airport to a country outside the EU, it's also worth having a quick look at your destination's customs rules around injectable medications some countries have specific restrictions on GLP-1s like semaglutide or tirzepatide
pharmacies, and personalized lifestyle support
You skip lunch